Detalles de la búsqueda
1.
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants.
bioRxiv
; 2024 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38370837
2.
Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial.
Lancet HIV
; 11(5): e285-e299, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38692824
3.
Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies.
Curr Protoc Immunol
; 131(1): e116, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33215858
4.
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies.
medRxiv
; 2020 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32511572
Resultados
1 -
4
de 4
1
Próxima >
>>